Union Sues J&J for Blocking Biosimilar, Generics Competition

A worker benefits fund filed a lawsuit against Johnson & Johnson this week for allegedly maintaining an illegal monopoly for its Crohn’s disease drug Remicade.
Source: Drug Industry Daily